Related Experiment Video
Updated: Jul 15, 2025

Laser Capture Microdissection of Highly Pure Trabecular Meshwork from Mouse Eyes for Gene Expression Analysis
Published on: June 3, 2018
Effect of antihypertensive medications on the risk of open-angle glaucoma
Jihei Sara Lee1, Hye Ryeong Cha2, Hyoung Won Bae1
1Department of Ophthalmology, Severance Hospital, Institute of Vision Research, Yonsei University, 50 Yonsei-Ro, Seodaemun-Gu, Seoul, 03722, Republic of Korea.
Insights
Certain blood pressure medications, specifically angiotensin receptor blockers (ARBs) and calcium channel blockers (CCBs), may slightly increase open-angle glaucoma (OAG) risk in hypertensive patients. Further research is needed to clarify these associations.
Area of Science:
- Ophthalmology
- Pharmacology
- Cardiology
Background:
- Hypertension (HTN) is a prevalent condition often managed with antihypertensive medications.
- Open-angle glaucoma (OAG) is a leading cause of irreversible blindness.
- The potential impact of antihypertensive therapies on OAG risk remains an area of investigation.
Purpose of the Study:
- To investigate the association between specific classes of antihypertensive medications and the risk of developing open-angle glaucoma (OAG) in patients with hypertension (HTN).
Main Methods:
- A retrospective cohort study involving 5,195 patients diagnosed with HTN and subsequently OAG.
- Matched controls (n=25,975) were selected based on hypertension diagnosis date, residential area, insurance, and economic status.
- Antihypertensive medications were categorized into five types: ACE inhibitors, ARBs, CCBs, beta-blockers, and diuretics. Relative risks were calculated after adjusting for multiple confounding factors.
Main Results:
- Angiotensin receptor blockers (ARBs) and calcium channel blockers (CCBs) were associated with a slight increase in OAG risk (RR 1.1087 and 1.0694, respectively).
- Combinations of ARBs with diuretics and CCBs also showed a modest increase in OAG risk.
- Overall, antihypertensive medication use demonstrated a small increase in OAG risk.
Conclusions:
- Antihypertensive medications, particularly ARBs and CCBs, may be associated with a small but statistically significant increase in the risk of open-angle glaucoma.
- Further research is warranted to elucidate the complex interplay between blood pressure, medication effects, and OAG development.
Abstract:
The purpose of this study was to identify the effect of antihypertensive medication on risks of open-angle glaucoma (OAG) among patients diagnosed with hypertension (HTN). A total of 5,195 patients, who were diagnosed with HTN between January 1, 2006 and December 31, 2015, and subsequently diagnosed with OAG, were selected for analysis. For each OAG patient, 5 non-glaucomatous, hypertensive controls were matched (n = 25,975) in hypertension diagnosis date, residential area, insurance type and economic status. Antihypertensive medications were stratified into 5 types: angiotensin converting enzyme inhibitor (ACEi), angiotensin receptor blockers (ARB), calcium channel blockers (CCB), β-blockers and diuretics. Relative risks were calculated. After adjusting for age, sex, body mass index, lifestyle, comorbidities, blood pressure (BP), follow-up duration, and use of other types of antihypertensive drugs, ARB and CCB were found to slightly increase OAG risks (RR 1.1087 (95% CI 1.0293-1.1942); 1.0694 (1.0077-1.1349), respectively). Combinations of ARB with diuretics (1.0893 (1.0349-1.1466)) and CCB (1.0548 (1.0122-1.0991)) also increased OAG risks. The risks for OAG were found to increase by antihypertensive medication use, but the effects appeared to be small. Further studies are necessary to identify the associations of increased BP, medication and therapeutic effect with OAG.
Related Concept Videos
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Angle Closure Glaucoma: Treatment
Glaucoma: Overview
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Drugs: Action of Diuretics

